These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36331823)

  • 21. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study.
    Ren X; Wang X
    Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention.
    Tian M; Li R; Shan Z; Wang DW; Jiang J; Cui G
    Lipids Health Dis; 2019 Nov; 18(1):202. PubMed ID: 31744496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography.
    Ling Y; Jiang J; Wu B; Gao X
    J Clin Lipidol; 2017; 11(3):646-656. PubMed ID: 28506386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
    Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
    Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
    Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
    Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease.
    Peloso GM; Nomura A; Khera AV; Chaffin M; Won HH; Ardissino D; Danesh J; Schunkert H; Wilson JG; Samani N; Erdmann J; McPherson R; Watkins H; Saleheen D; McCarthy S; Teslovich TM; Leader JB; Lester Kirchner H; Marrugat J; Nohara A; Kawashiri MA; Tada H; Dewey FE; Carey DJ; Baras A; Kathiresan S
    Circ Genom Precis Med; 2019 May; 12(5):e002376. PubMed ID: 30939045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis.
    Helgadottir A; Thorleifsson G; Snaebjarnarson A; Stefansdottir L; Sveinbjornsson G; Tragante V; Björnsson E; Steinthorsdottir V; Gretarsdottir S; Helgason H; Saemundsdottir J; Olafsson I; Thune JJ; Raja AA; Ghouse J; Olesen MS; Christensen A; Jacobsen RL; Dowsett J; Bruun MT; Nielsen K; Knowlton K; Nadauld L; Benediktsson R; Erikstrup C; Pedersen OB; Banasik K; Brunak S; ; Bundgaard H; Ostrowski SR; Sulem P; Arnar DO; Thorgeirsson G; Thorsteinsdottir U; Gudbjartsson DF; Stefansson K; Holm H
    Eur J Prev Cardiol; 2022 Dec; 29(18):2374-2385. PubMed ID: 36125206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study.
    Yun SY; Rim JH; Kang H; Lee SG; Lim JB
    Ann Lab Med; 2023 May; 43(3):237-243. PubMed ID: 36544335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.
    Liem AH; van de Woestijne AP; Roeters van Lennep HW; Zwinderman AH; van der Steeg WA; Jukema JW
    Curr Med Res Opin; 2008 Feb; 24(2):359-64. PubMed ID: 18081989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese.
    Chien KL; Hsu HC; Su TC; Chen MF; Lee YT; Hu FB
    J Lipid Res; 2007 Nov; 48(11):2499-505. PubMed ID: 17698856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women.
    Dugani SB; Moorthy MV; Li C; Demler OV; Alsheikh-Ali AA; Ridker PM; Glynn RJ; Mora S
    JAMA Cardiol; 2021 Apr; 6(4):437-447. PubMed ID: 33471027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial differences in low-density lipoprotein particle size in families at high risk for premature coronary heart disease.
    Kral BG; Becker LC; Yook RM; Blumenthal RS; Kwiterovich PO; Otvos JD; Becker DM
    Ethn Dis; 2001; 11(2):325-37. PubMed ID: 11456008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.
    Boekholdt SM; Arsenault BJ; Mora S; Pedersen TR; LaRosa JC; Nestel PJ; Simes RJ; Durrington P; Hitman GA; Welch KM; DeMicco DA; Zwinderman AH; Clearfield MB; Downs JR; Tonkin AM; Colhoun HM; Gotto AM; Ridker PM; Kastelein JJ
    JAMA; 2012 Mar; 307(12):1302-9. PubMed ID: 22453571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
    Mora S; Buring JE; Ridker PM; Cui Y
    Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.
    Robinson JG; Wang S; Jacobson TA
    Am J Cardiol; 2012 Nov; 110(10):1468-76. PubMed ID: 22906895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins.
    Rasouli M; Kiasari AM
    Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein B levels and related factors in a rural white South African community--the CORIS study. Coronary Risk Factor Study.
    Steyn K; Rossouw JE; Weight MJ; Fourie JM; Benadé AJ; Jooste PL; Chalton DO; Wolmarans P
    S Afr Med J; 1996 Apr; 86(4):359-64. PubMed ID: 8693373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.